C21 Investments Inc. (CSE:CXXI)
Canada
· Delayed Price · Currency is CAD 0.425
-0.015 (-3.41%)
Mar 9, 2026, 3:59 PM EST
C21 Investments Revenue
C21 Investments had revenue of $8.14M USD in the quarter ending December 31, 2025, with 2.95% growth. This brings the company's revenue in the last twelve months to $33.27M, up 24.19% year-over-year. In the fiscal year ending March 31, 2025, C21 Investments had annual revenue of $30.12M with 12.42% growth.
Revenue (ttm)
$33.27M
Revenue Growth
+24.19%
P/S Ratio
1.14
Revenue / Employee
$241.09K
Employees
138
Market Cap
51.93M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 30.12M | 3.33M | 12.42% |
| Mar 31, 2024 | 26.79M | -1.50M | -5.29% |
| Jan 31, 2024 | 28.29M | -603.21K | -2.09% |
| Jan 31, 2023 | 28.89M | -4.09M | -12.41% |
| Jan 31, 2022 | 32.98M | -483.09K | -1.44% |
| Jan 31, 2021 | Pro | Pro | Pro |
| Jan 31, 2020 | Pro | Pro | Pro |
| Jan 31, 2019 | Pro | Pro | Pro |
| Jan 31, 2018 | Pro | Pro | Pro |
| Jan 31, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LSL Pharma Group | 26.80M |
| Leef Brands | 45.21M |
| ZYUS Life Sciences | 465.00K |
| Vext Science | 66.63M |
| Decibel Cannabis Company | 109.31M |
| BioNxt Solutions | 15.82K |
| Planet 13 Holdings | 151.05M |
| iAnthus Capital Holdings | 209.79M |